Quantitative analysis of proliferation, apoptosis, and angiogenesis in retinoblastoma and their association with the clinicopathologic parameters

Japanese Journal of Ophthalmology

Volumn 47, Issue 6, 2003, Pages 565-571

  Kerimoǧglu, Hürkan ^a   Kiratli, Hayyam ^a   Dinçtürk, Ayşse Ayhan ^a   Söylemezoǧlu, Figen ^a   Bilgiç, Sevgül ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Apoptosis; In situ terminal deoxynucleotidyl transferase mediated dUTP nick end labeling; Proliferative index; Retinoblastoma

Indexed keywords

ANTIBODY; CD34 ANTIBODY; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CALCULATION; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENUCLEATION; EVALUATION; EVISCERATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NICK END LABELING; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RETINOBLASTOMA; STAINING; STATISTICAL ANALYSIS;

EID: 0242467852     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjo.2003.09.002     Document Type: Article

References (35)

1. Harbour J.W. Molecular basis of low penetrance retinoblastoma. Arch Ophthalmol. 119:2001;1699-1704.
2. Herwig S., Strauss M. The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem. 246:1997;581-601.
3. Hu Q.J., Lees J.A., Buchkovich K.J., Harlow E. The retinoblastoma protein physically associates with the human cdc2 kinase. Mol Cell Biol. 12:1992;971-980.
4. Giuliano M., Lauricella M., Vassallo E., Carabillo M., Vento R., Tesoriere G. Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors. Invest Ophthalmol Vis Sci. 39:1998;1300-1311.
5. Kerr J.F., Winterford C.M., Harmon B.V. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 73:1994;2013-2026.
6. Gerdes J., Lemke H., Baisch H., Wacker H.H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation: associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 133:1984;1710-1715.
7. Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 31:1983;13-20.
8. Wyllie A.H. The biology of cell death in tumours. Anticancer Res. 5:1985;131-136.
9. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257.
10. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
11. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med. 333:1995;1757-1763.
12. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med. 1:1995;27-31.
13. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 147:1995;9-19.
14. Redler L.D., Ellsworth R.M. Prognostic importance of choroidal invasion in retinoblastoma. Arch Ophthalmol. 90:1973;294-296.
15. Stannard C., Lipper S., Sealy R., Sevel D. Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastases. Br J Ophthalmol. 63:1979;560-570.
16. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol. 1:1990;199-206.
17. Matsumoto M., Komiyama K., Okaue M., et al. Predicting tumor metastasis in patients with oral cancer by means of the proliferation marker Ki67. J Oral Sci. 41:1999;53-56.
18. Sökmensüer C., Gedikoglu G., Uzunalimoglu B. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study. Hepatogastroenterology. 48:2001;720-723.
19. Watanabe T., Oda Y., Tamiya S., Kinukawa N., Masuda K., Tsuneyoshi M. Malignant peripheral nerve sheath tumors: high Ki67 labelling index is the significant prognostic indicator. Histopathology. 39:2001;187-197.
20. Wu T.T., Chen J.H., Lee Y.H., Huang J.K. The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma. J Urol. 163:2000;758-760.
21. Losa M., Barzaghi R.L., Mortini P., et al. Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors: comparison between micro- and macroadenomas. Am J Pathol. 156:2000;245-251.
22. Kim J.C., Chi J.G., Choi H.S., et al. Proliferation not apoptosis as a prognostic indicator in retinoblastoma. Virchows Arch. 434:1999;301-305.
23. Orjuela M., Orlow I., Dudas M., et al. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma. Hum Pathol. 32:2001;537-544.
24. Madigan M.C., Penfold P.L. Human retinoblastoma: a morphological study of apoptotic, leukocytic and vascular elements. Ultrastruct Pathol. 21:1997;95-107.
25. Cha S.C., Suh K.S., Song K.S., Lim K. Cell death in retinoblastoma; electron microscopic, immunohistochemical and DNA fragmentation studies. Ultrastruct Pathol. 24:2000;23-32.
26. Weidner N. Intratumoral microvessel density as a prognostic factor in cancer. Am J Pathol. 147:1995;9-19.
27. Weidner N., Carroll P.R., Flax J., Blumenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 143:1993;401-409.
28. Guidi A.J., Schnitt S.J., Fischer L., et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer. 80:1997;1945-1953.
29. Wakisaka N., Wen Q.H., Yoshizaki T., et al. Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma. Laryngoscope. 109:1999;810-814.
30. Nativ O., Sabo E., Reiss A., Wald M., Madjar S., Moskovitz B. Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma. Urology. 51:1998;693-696.
31. Schoell W.M., Pieber D., Reich O., et al. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Cancer. 80:1997;2257-2262.
32. Simpson J.F., Ahn C., Battifora H., Esteban J.M. Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer. 77:1996;2077-2085.
33. Mäkitie T., Summanen P., Tarkkanen A., Kivelä T. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci. 40:1999;2471-2480.
34. Albert D.M., Tapper D., Robinson N.L., Felman R. Retinoblastoma and angiogenesis activity. Retina. 4:1984;189-194.
35. Tapper D., Langer R., Bellows A.R., Folkman J. Angiogenesis capacity as a diagnostic marker for human eye tumors. Surgery. 86:1979;36-40.